Kategorien
-
Adhesives
5
Amines
93
Amino Acids
181
Analytical Reagents
673
Antibiotics
252
Bioactive Small Molecules
718
Aroma Chemicals
206
Biochemicals
1014
Boronic Acids
4
Buffers
99
Building Blocks
1782
Carbohydrates
176
Catalysts
99
Chiral Compounds
54
Coccus nucifera oil
0
Detergents
59
Diagnostic Raw Materials
251
Flavours and Fragrance Materials
204
Fluorinated Products
42
Furans
5
Gases in Solution
50
Grignard Reagents
19
HPLC Reagents
8
Imidazoles
17
Indoles
42
Inorganic Chemicals
324
Ion-Pair Reagents
24
Ligands
80
Organics
1307
Oxazoles
3
Peptide Reagents
90
Phenols
44
Picolines
0
Piperazines
10
Pyrazines
2
Pyridines
54
Pyrimidines
30
Quaternary Ammonium salts
44
Reagents
97
Research Organics & Inorganics
753
Salts
284
Sealing Compounds
1
Sherclin
2
Solvents
124
Stains & Indicators
289
Sugars
63
Tailor-made solutions
3
Testing Standards
4
Uncategorised
172
Water Analysis
10
Cephalexin monohydrate
(89984984 | 23325-78-2)
| CAS: | 23325-78-2 |
|---|---|
| Molekularformel: | C16H17N3O4S |
| Molekulargewicht: | 365.40 |
| Verfügbarkeit: | Auf Lager |
|---|---|
| Downloads: | | |
| 89984984-25g | 25g | £46.50 | |
| Bulk Menge | |||
| 89984984-25g | 25g | €65.10 | |
| Bulk Menge | |||
| 89984984-25g | 25g | $69.80 | |
| Bulk Menge | |||
Sicherheitsdatenblatt
Analysezertifikat
Produktbeschreibung
| Product Code | 89984984 | ||||
| Product Name | Cephalexin monohydrate | ||||
| Categories | Antibiotics Bioactive Small Molecules | ||||
| CAS | 23325-78-2 | ||||
| Molecular Formula | C16H17N3O4S | ||||
| Molecular Weight | 365.40 | ||||
| Storage Details | Ambient | ||||
| Harmonised Tariff Code | 2941900000 |
Produktspezifikation
| Water | 4.0 to 8.0% | ||||
| Impurity B | ≤ 1.0% | ||||
| pH | 4.0 - 5.5 | ||||
| Specific optical rotation | +149 to +158 | ||||
| Assay (anhydrous basis) | 95.0 - 102.0% | ||||
| Total Impurities | ≤ 3.0% | ||||
| Appearance | White to off-white powder | ||||
| Any other impurity | ≤ 1.0% |
Sicherheitsinformation
| Pictograms |
|
||||
| Signal word | danger | ||||
| Hazard statements |
|
||||
| Precautionary statements |
|